default author photo

Daniela Scattolin

affiliation not provided to SSRN

SCHOLARLY PAPERS

3

DOWNLOADS

127

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database

Number of pages: 24 Posted: 15 May 2025
“Vito Fazzi” Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, Università degli Studi di Udine - Azienda Sanitaria Universitaria Integrata di Udine, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Pederzoli Hospital-Peschiera del Garda, University of Pavia, University Hospital of Parma, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, University of Pisa, University Hospital Careggi, affiliation not provided to SSRN, Cardinal Massaia Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, Università degli Studi di Genova, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, affiliation not provided to SSRN, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 67 (916,100)

Abstract:

Loading...

alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib

2.

Outcome and Safety of Lurbinectedin as Compassionate Use in Extensive Stage Small Cell Lung Cancer: A Multicentric International Cohort

Number of pages: 22 Posted: 02 Jun 2025
affiliation not provided to SSRN, Erasmus University Rotterdam, Istituto Oncologico Veneto – IRCCS, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine
Downloads 31 (1,304,549)

Abstract:

Loading...

small cell lung cancer, lurbinectedin, real-world, effectiveness

3.

CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

Number of pages: 10 Posted: 07 Jan 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Università degli Studi di Bari “Aldo Moro” (UNIBA), affiliation not provided to SSRN, Humanitas Gavazzeni, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Ferrara, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Padova - Department of Cardiac, Thoracic, Vascular Science and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 29 (1,332,057)

Abstract:

Loading...

Pleural Mesothelioma, Immunotherapy, perioperative, pleurectomy, multimodality